Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4552-4557

  Starostik, Petr ^a   Manshouri, Taghi ^a   O'Brien, Susan ^a   Freireich, Emil ^a   Kantarjian, Hagop ^a   Haidar, Mohammad ^a   Lerner, Susan ^a   Keating, Michael ^a   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; ATAXIA TELANGIECTASIA; B CELL LEUKEMIA; CELL CYCLE; CHROMOSOME 11Q; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION FUNCTION; DNA REPAIR; GENE LOCATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LEUKEMOGENESIS; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; SURVIVAL TIME;

CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LOSS OF HETEROZYGOSITY; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032532095     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics. CA Cancer J. Clin., 45: 8-30, 1995.
2. O'Brien, S., del Giglio, A., and Keating, M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood, 85: 307-318, 1995.
3. Montserrat, E., Binet, J. L., Dighiero, G., Gale, R. P., Juliusson, G., Keating, M., and Rai, K. R. Chronic lymphoproliferative disorders. Rev. Invest. Clin. (Suppl.): 52-58, 1994.
4. Döhner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P. R., Poustka, A., Hunstein, W., and Lichter, P. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85: 1580-1589, 1995.
5. Garcia-Marco, J., Matutes, E., Morilla, R., Ellis, J., Oscier, D., Fantes, J., Catovsky, D., and Price, C. Trisomy 12 in B-cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br. J. Haematol., 87: 44-50, 1994.
6. Oscier, D. G. Cytogenetic and molecular abnormalities in chronic lymphocytic leukemia. Blood Rev., 8: 88-97, 1994.
7. Garcia-Marco, J. A., Caldas, C., Price, C. M., Wiedemann, L. M., Ashworth, A., and Catovsky, D. Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood, 88: 1568-1575, 1996.
8. Kroft, S. H., Finn, W. G., Kay, N. E., and Peterson, L. C. Isolated 13q14 abnormalities and normal karyotypes are associated with typical lymphocyte morphology in B-cell chronic lymphocytic leukemia. Am. J. Clin. Pathol., 107: 275-282, 1997.
9. Newcomb, E. W., Thomas, A., Selkirk, A., Lee, S. Y., and Potmesil, M. Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation. Cancer Res., 55: 2044-2047, 1995.
10. Liu, Y., Hermanson, M., Grander, D., Merup, M., Wu, X., Heyman, M., Rasool, O., Juliusson, G., Gahrton, G., and Detlofsson, R. 13q deletions in lymphoid malignancies. Blood, 86: 1911-1915, 1995.
11. Stilgenbauer, S., Leupolt, E., Ohl, S., Weiss, G., Schroder, M., Fischer, K., Bentz, M., Lichter, P., and Döhner, H. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res., 55: 3475-3477, 1995.
12. Garcia-Marco, J. A., Price, C. M., and Catovsky, D. Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genet. Cytogenet., 94: 52-58, 1997.
13. Fegan, C. D., Robinson, H., Thompson, P., Whittaker, J. A., and White, D. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia (Baltimore), 9: 2003-2008, 1995.
14. Stilgenbauer, S., Liebisch, P., James, M. R., Schroder, M., Schlegelberger, B., Fischer, K., Bentz, M., Lichter, P., and Döhner, H. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lympho-proliferative disorders. Proc. Natl. Acad. Sci. USA, 93: 11837-11841, 1996.
15. Döhner, H., Stilgenbauer, S., James, M. R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W., and Lichter, P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89: 2516-2522, 1997.
16. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. F., Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC), 268: 1749-1753, 1995.
17. Uziel, T., Savitsky, K., Platzer, M., Ziv, Y., Helbitz, T., Nehls, M., Boehm, T., Rosenthal, A., Shiloh, Y., and Rotman, G. Genomic organization of the ATM gene. Genomics, 33: 317-320, 1996.
18. Chen, G., and Lee, E-H. The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J. Biol. Chem., 271: 33693-33697, 1996.
19. Brown, K. D., Ziv, Y., Sadanandan, S. N., Chessa, L., Collins, F. S., Shiloh, Y., and Tagle, D. A. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-graded following genome damage. Proc. Natl. Acad. Sci. USA, 94: 1840-1845, 1997.
20. Hawly, R. S., and Friend, S. H. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev., 10: 2383-2388, 1996.
21. Thacker, J. Cellular radiosensitivity in ataxia-telangiectasia. Int. J. Radiat. Biol., 66: S87-S96, 1994.
22. Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., and Baltimore, D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev., 10: 2411-2422, 1996.
23. Hecht, F., and Hecht, B. K. Cancer in ataxia-telangiectasia patients. Cancer Genet. Cytogenet., 46: 9-19, 1990.
24. Reitnauer, P. J., Morrell, D., and Chase, C. L. Breast and other cancers in ataxiatelangiectasia. N. Engl. J. Med., 325: 1831-1836, 1987.
25. Swift, M., Morrell, D., Massey, R. B., and Chase, C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med., 325: 1831-1836, 1991.
26. Easton, D. F. Cancer risks in A-T heterozygotes. Int. J. Radial. Biol., 66: S177-S182, 1994.
27. Meyn, M. S. High spontaneous intrachromosomal recombination rates in ataxiatelangiectasia. Science (Washington DC), 260: 1327-1330, 1993.
28. Vorechovsky, I., Rasio, D., Luo, L., Monaco, C., Hammarström, L., Webster, A. D. B., Zaloudik, J., Barbanti-Brodano, Q., James, M., Russo, G., Croce, C. M., and Negrini, M. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumor reveals no evidence for mutation. Cancer Res., 56: 2726-2732, 1996.
29. FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, P., Finkelstein, D. M., Isselbacher, K. J., and Haber, D. A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet., 15: 307-310, 1997.
30. Vorechovsky, I., Luo, L., Dyer, M. J. S., Catovsky, D., Amlot, P. L., Yaxley, J. C., Foroni, L., Hammarström, L., Webster, A. D. B., and Yuille, M. A. R. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukemia. Nat. Genet., 17: 96-99, 1997.
31. Lakin, N. D., Weber, P., Stankovic, T., Rottinghaus, S. T., Taylor, A. M., and Jackson, S. P. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene, 13: 2707-2716, 1996.
32. Dierlamm, J., Michaux, L., Criel, A., Wlodarska, I., Van den Berghe, H., and Hossfeld, D. K. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genet. Cytogenet., 94: 27-35, 1997.
33. Pabst, T., Schwaller, J., Bellomo, M. J., Oestreicher, M., Mühlematter, D., Tichelli, A., Tobler, A., and Fey, M. F. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood, 88: 1026-1034, 1996.
34. Rasio, D., Negrini, M., and Croce, C. M. Genomic organization of the ATM locus involved in ataxia-telangiectasia. Cancer Res., 55: 6053-6057, 1995.
35. Russell, J. E., and Liebhaber, S. A. The stability of human β-globin mRNA is dependent on structural determinants positioned within its 3′ untranslated region. Blood, 87: 5314-5323, 1996.
36. Shakin, S. H., and Liebhaber, S. A. Destabilization of messenger RNA/complementary DNA duplexes by the elongating 80 S ribosome. J. Biol. Chem., 261: 16018-16025, 1986.
37. Swift, M., Chase, C. L., and Morrell, D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet. Cytogenet., 46: 21-27, 1990.
38. Pottern, L. M., Linet, M., Blair, A., Dick, F., Burmeister, L. F., Gibson, R., Schuman, L. M., and Fraumeni, J. F. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk. Res., 15: 305-314, 1991.
39. Radovanovic, Z., Markovic-Denic, L., and Jankovic, S. Cancer mortality of family members of patients with chronic lymphocytic leukaemia. Eur. J. Epidemiol., 10: 211-213, 1994.